Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.
Learn more about this strategic acquisition.
Cell Phenotyping Without Complexity
Accellix is bringing automated sample preparation, flow cytometry and data analysis into the GMP manufacturing suite.
What is the Accellix Instrument?
This two minute video will give you a lot of insight into the state-of-the-art Accellix Instrument and automated cell phenotyping platform.
Learn More
The Accellix Automated Cell Phenotyping Platform
Instrument
Small footprint bench-top platform, manufacturing suite compatible and fan-less operation that provides minimal maintenance 24/7.
Cartridge
A microfluidic cartridge and unitized dried down reagents that provide automated sample preparation, increased reproducibility and accuracy by reducing manual handling.
Software
Configurable software to meet QC Requirements with touchscreen interface and easy navigation.
Assays
Custom and off-the-shelf assays for every step in your process.
A Revolution in the science of flow cytometry
Cartridge Based Assays
Automated sample preparation, increasing reproducibility and accuracy by reducing handling.
Learn More
Fully Automated
Fully automated data analysis and auto classification process tailored to customer's needs.
Learn More
Used in cellular and cancer research around the globe
The Accellix Automated Cell Phenotyping Platform brings the power of flow cytometry directly into the GMP manufacturing suite. From automating sample preparation, data acquisition and analysis, the platform can streamline complex incoming, in-process, and release quality control testing throughout the cell therapy manufacturing workflow.
Connect with Accellix at these events:
Blood Centers of America (BCA) Advanced Therapies Network
February 17, 2026 – February 19, 2026
Fort Myers, FL
